Literature DB >> 3039632

Plurihormonal pituitary adenomas.

B W Scheithauer, E Horvath, K Kovacs, E R Laws, R V Randall, N Ryan.   

Abstract

Plurihormonal adenomas of the pituitary, ie, tumors that engage in the production of unusual combinations of hormones, represent approximately 10% to 15% of all adenomas. Such tumors comprise in excess of 50% of adenomas in the setting of acromegaly and occur with somewhat greater frequency in childhood and adolescence than in adulthood. Eight percent are associated with multiple endocrine neoplasia, type I. The most common variant of plurihormonal adenoma produces growth hormone, prolactin, and one or more glycoprotein hormones, the most common being TSH. Clinical effects most often reflect the presence of growth hormone, and to a lesser extent, prolactin cells; expression of glycoprotein hormone production is rare. The tumors are more often macroadenomas (80%) than microadenomas (20%) and demonstrate gross invasion in 50% of cases. Plurihormonal adenomas may be ultrastructurally monomorphous, bimorphous, or trimorphous; thus, one morphologic cell type may elaborate several hormones.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3039632

Source DB:  PubMed          Journal:  Semin Diagn Pathol        ISSN: 0740-2570            Impact factor:   3.464


  32 in total

1.  Pituitary tumours.

Authors:  A Agarwal; A K Mahapatra; M C Sharma
Journal:  Indian J Pediatr       Date:  1998 Jan-Feb       Impact factor: 1.967

2.  Tumefactive postmenopausal gonadotroph cell hyperplasia.

Authors:  Mark Jentoft; Bernd W Scheithauer; Olga Moshkin; Eva Horvath; Phillip C Collins; Luis V Syro; Kalman Kovacs
Journal:  Endocr Pathol       Date:  2012-06       Impact factor: 3.943

3.  Ghrelin- and serotonin-producing gastric carcinoid.

Authors:  Eleanor Latta; Fabio Rotondo; Lawrence A Leiter; Eva Horvath; Kalman Kovacs
Journal:  J Gastrointest Cancer       Date:  2012-06

Review 4.  Human pituitary adenomas. Recent advances in morphological studies.

Authors:  G Giannattasio; M Bassetti
Journal:  J Endocrinol Invest       Date:  1990-05       Impact factor: 4.256

5.  Cytokeratin distribution and functional properties of growth hormone-producing pituitary adenomas.

Authors:  Toshiaki Sano; Shozo Yamada; Takashi Hi Rose; Kazuo Hizawa
Journal:  Endocr Pathol       Date:  1994-06       Impact factor: 3.943

6.  From macroprolactinoma to concomitant ACTH-PRL hypersecretion with Cushing's disease.

Authors:  M Barausse; R Attanasio; D Dallabonzana; G Oppizzi; S Veronese; G Lasio; L G Valentini; R Cozzi
Journal:  J Endocrinol Invest       Date:  2000-02       Impact factor: 4.256

7.  Silent somatotroph adenomas of the human pituitary. A morphologic study of three cases including immunocytochemistry, electron microscopy, in vitro examination, and in situ hybridization.

Authors:  K Kovacs; R Lloyd; E Horvath; S L Asa; L Stefaneanu; D W Killinger; H S Smyth
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

8.  Plurihormonal pituitary tumors: Beyond the one cell-one hormone theory.

Authors:  Kamal Thapar; Lucia Stefaneanu; Kalman Kovacs; Eva Horvath; Sylvia L Asa
Journal:  Endocr Pathol       Date:  1993-03       Impact factor: 3.943

9.  Growth hormone (GH) and prolactin (PRL) gene expression and immunoreactivity in GH- and PRL-producing human pituitary adenomas.

Authors:  J Li; L Stefaneanu; K Kovacs; E Horvath; H S Smyth
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

10.  Immunohistochemistry as a predictor of clinical outcome in patients given postoperative radiation for subtotally resected pituitary adenomas.

Authors:  J J Kovalic; G Mazoujian; D W McKeel; B B Fineberg; P W Grigsby
Journal:  J Neurooncol       Date:  1993-06       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.